EmpagliflozinSGLT2 Inhibitor (Antidiabetic Preparations) Indication: • Emjard™ is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2DM).• Emjard™ is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. Dosage & Administration: The recommended dose of […]